Use of Isoniazid [H] Mono/Poly DR-TB Regimen in Special Situations
Use of Isoniazid [H] Mono/Poly DR-TB Regimen in Special Situations
Adverse Drug Events: H Mono/Poly DR-TB Regimen
- Read more about Adverse Drug Events: H Mono/Poly DR-TB Regimen
- Log in to post comments
Adverse Drug Events: H Mono/Poly DR-TB Regimen
Interim Treatment Outcomes of DR-TB Cases
- Read more about Interim Treatment Outcomes of DR-TB Cases
- Log in to post comments
Interim Treatment Outcomes of DR-TB Cases
Flow Chart of H Mono/Poly DR-TB Patients from Diagnosis to Treatment Outcome
Flow Chart of H Mono/Poly DR-TB Patients from Diagnosis to Treatment Outcome
Flow Chart of MDR/RR-TB Patients on Shorter Oral Bedaquiline-containing Regimen from Diagnosis to Treatment Outcome
Flow Chart of MDR/RR-TB Patients on Shorter Oral Bedaquiline-containing Regimen from Diagnosis to Treatment Outcome
Need for Palliative Care in DR-TB Patients
- Read more about Need for Palliative Care in DR-TB Patients
- Log in to post comments
Need for Palliative Care in DR-TB Patients
Preventive Treatment for Contacts of DR-TB Patients
Preventive Treatment for Contacts of DR-TB Patients: WHO Recommendations
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB
-
Describe the methods used under the NTEP to ensure the reliability of Drug-resistant Tuberculosis (DR-TB) diagnostic tests:
a) Quality Assurance (QA) and control of tests
b) Proficiency testing
Quality Assurance of Anti-TB Drugs
- Read more about Quality Assurance of Anti-TB Drugs
- Log in to post comments
QA of drugs
Methods for Pharmacovigilance Activity Reporting
Methods for Pharmacovigilance Activity Reporting